Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam.

STUDY OBJECTIVES REM sleep behavior disorder (RBD) is characterized by loss of the normal muscle atonia during REM sleep associated with disruptive motor activity related to the acting out of dreams. There is frequently injury to the patient or bed partner, and treatment is usually required. Clonazepam has been the first-line therapy for many years, with 2 large case series reporting efficacy with few side effects in the majority of patients. However, long-acting hypnotics in the elderly or those with cognitive impairment can be associated with adverse events especially unacceptable daytime sedation, confusion, and exacerbation of existing sleep apnea. METHODS We reviewed 39 patients with confirmed RBD who were treated within our regional sleep center, assessing both efficacy and side effects of drug therapies. RESULTS Adverse effects were reported by 58% of the patients using clonazepam, with 50% either discontinuing the drug or reducing the dose. This prompted us review the side effects of clonazepam in detail and to look for alternative therapies. We report several novel and effective therapies, in particular zopiclone, in a series of patients under long-term follow-up for RBD. CONCLUSIONS There are alternatives to clonazepam therapy for RBD which can be as effective and may be better tolerated.

[1]  M. Vendette,et al.  Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder , 2008, Neurology.

[2]  R. Postuma,et al.  Update on the pharmacology of REM sleep behavior disorder , 2006, Neurology.

[3]  Markus H Schmidt,et al.  Use of pramipexole in REM sleep behavior disorder: results from a case series. , 2006, Sleep medicine.

[4]  Julien Doyon,et al.  Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases , 2006, The Lancet Neurology.

[5]  A. Lang,et al.  Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder , 2006, Neurology.

[6]  J. Montplaisir,et al.  The effects of pramipexole in REM sleep behavior disorder , 2003, Neurology.

[7]  B. Boeve,et al.  Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. , 2003, Sleep medicine.

[8]  M. Mahowald,et al.  REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. , 2002, Sleep.

[9]  N. Uchimura,et al.  Melatonin therapy for REM sleep behavior disorder. , 2001, Psychiatry and clinical neurosciences.

[10]  B. Boeve,et al.  Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. , 2000, Brain : a journal of neurology.

[11]  Daniel J Buysse,et al.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. , 1999, Sleep.

[12]  D. Kunz,et al.  Melatonin as a therapy in rem sleep behavior disorder patients: An open‐labeled pilot study on the possible influence of melatonin on rem‐sleep regulation , 1999, Movement disorders : official journal of the Movement Disorder Society.

[13]  M. Johns,et al.  Sleepiness in different situations measured by the Epworth Sleepiness Scale. , 1994, Sleep.

[14]  Jacques Montplaisir,et al.  Polysomnographic features of REM sleep behavior disorder , 1992, Neurology.

[15]  Mahowald,et al.  Symposium: Normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature. , 1993, Journal of sleep research.